Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis

Ourania Koltsida (Athens, Greece), Ourania Koltsida, Evgenia Synolaki, Athanasios Stavropoulos, Pasxalis Sideras, Nikolaos Koulouris, Dimitrios Boumpas, Grigorios Stratakos

Source: International Congress 2016 – Connective tissue disorders
Session: Connective tissue disorders
Session type: Poster Discussion
Number: 4875
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ourania Koltsida (Athens, Greece), Ourania Koltsida, Evgenia Synolaki, Athanasios Stavropoulos, Pasxalis Sideras, Nikolaos Koulouris, Dimitrios Boumpas, Grigorios Stratakos. Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis. Eur Respir J 2016; 48: Suppl. 60, 4875

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014

Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009



Significance of connective tissue disease features in idiopathic interstitial pneumonia
Source: Eur Respir J 2012; 39: 661-668
Year: 2012



Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


The ratio AGE/RAGE is increased in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016